<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="pc" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">pc</book-part-id>
      <title-group>
        <title>Pachyonychia Congenita</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Smith</surname>
            <given-names>Frances JD</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Centre for Dermatology and Genetic Medicine<break/>Division of Molecular Medicine<break/>Colleges of Life Sciences and Medicine, Dentistry &#x00026; Nursing<break/>Medical Sciences Institute<break/>Dundee, United Kingdom</aff>
          <email>f.j.d.smith@dundee.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hansen</surname>
            <given-names>C David</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Dermatology<break/>University of Utah<break/>Salt Lake City, Utah</aff>
          <email>david.hansen@hsc.utah.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hull</surname>
            <given-names>Peter R</given-names>
          </name>
          <degrees>MD, PhD, FRCPC</degrees>
          <aff>Department of Medicine<break/>University of Saskatchewan<break/>Saskatoon, Saskatchewan, Canada</aff>
          <email>peter.hull@usask.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaspar</surname>
            <given-names>Roger L</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Transderm, Inc<break/>Santa Cruz, California</aff>
          <email>roger.kaspar@transderminc.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schwartz</surname>
            <given-names>Mary E</given-names>
          </name>
          <degrees>LLD</degrees>
          <aff>PC Project<break/>Salt Lake City, Utah</aff>
          <email>mary.schwartz@pachyonychia.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>McLean</surname>
            <given-names>WH Irwin</given-names>
          </name>
          <degrees>DSc, FRSE</degrees>
          <aff>Centre for Dermatology and Genetic Medicine<break/>Division of Molecular Medicine<break/>Colleges of Life Sciences and Medicine, Dentistry &#x00026; Nursing<break/>Medical Sciences Institute<break/>Dundee, United Kingdom</aff>
          <email>w.h.i.mclean@dundee.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Milstone</surname>
            <given-names>Leonard M</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Dermatology<break/>Yale University<break/>New Haven, Connecticut</aff>
          <email>leonard.milstone@yale.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>van Steensel</surname>
            <given-names>Maurice</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Dermatology<break/>University Hospital Maastricht<break/>Maastricht, The Netherlands</aff>
          <email>m.van.steensel@mumc.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>O&#x02019;Toole</surname>
            <given-names>Edel</given-names>
          </name>
          <degrees>MD, PhD, FRCPI, FRCP</degrees>
          <aff>Centre for Cutaneous Research<break/>Barts &#x00026; the London School of Medicine and Dentistry, Queen Mary<break/>University of London<break/>London, England, United Kingdom</aff>
          <email>e.a.otoole@qmul.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sprecher</surname>
            <given-names>Eli</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Dermatology<break/>Tel Aviv Medical Center<break/>Tel Aviv, Israel</aff>
          <email>elisp@tlvmc.gov.il</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2006-01-27" date-type="created">
          <day>27</day>
          <month>1</month>
          <year>2006</year>
        </date>
        <date iso-8601-date="2014-07-24" date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2014</year>
        </date>
        <date iso-8601-date="2007-12-06" date-type="revised">
          <day>6</day>
          <month>12</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="pura-dis" document-type="chapter"><italic toggle="yes">PURA</italic>-Related Neurodevelopmental Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="phs" document-type="chapter">Pallister-Hall Syndrome</related-object>
      <abstract id="pc.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Pachyonychia congenita (PC) is characterized by hypertrophic nail dystrophy, painful palmoplantar keratoderma and blistering, oral leukokeratosis, pilosebaceous cysts (including steatocystoma and vellus hair cysts), palmoplantar hyperhydrosis, and follicular keratoses on the trunk and extremities.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>PC is diagnosed by clinical findings and by molecular genetic testing to detect a heterozygous pathogenic variant in one of the five keratin genes known to cause PC: <italic toggle="yes">KRT6A</italic>, <italic toggle="yes">KRT6B, KRT6C, KRT16</italic>, and <italic toggle="yes">KRT17</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Pain from the palmoplantar keratoderma may be reduced somewhat by limiting friction and trauma to the feet by minimizing walking or standing, reducing hydration of the stratum corneum by using wicking socks and ventilated footwear, selecting comfortable shoes, and maintaining ideal body weight. Foot care includes paring down hyperkeratotic areas and topical therapies for hyperkeratosis (emollients and lotions containing keratolyics). Care of thickened nails often requires the use of surgical or razor blades or sanders such as a Dremel<sup>&#x000ae;</sup> tool. Troublesome nails removed surgically frequently grow back in some form. Good oral hygiene and brushing gently with a soft toothbrush can improve thick, white patches on the tongue and oral mucosa. Secondary fungal and bacterial infections that require treatment are common; cysts usually do not require treatment but can be incised and drained if infected or painful. Bottle-fed infants with leukokeratosis may need a soft nipple with an enlarged opening. Rarely, young children with laryngeal thickening/growths need emergency surgery to re-establish the airway; however, surgery may exacerbate the condition.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Attention to pre- and post-grooming hygiene to prevent infection.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> High temperatures and high humidity may worsen the condition.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Pachyonychia congenita is inherited in an autosomal dominant manner. Approximately 40% of cases appear to be caused by a <italic toggle="yes">de novo</italic> pathogenic variant. A single case of germline mosaicism has been reported. The offspring of an affected individual have a 50% chance of inheriting the disorder. If the pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk is possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="pc.Diagnosis">
        <title>Diagnosis</title>
        <p>By age ten years a diagnostic triad of toenail thickening, plantar keratoderma, and plantar pain was reported by 97% of individuals with genetically confirmed pachyonychia congenita (PC) [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.pachyonychia.org/">International Pachyonychia Research Registry</ext-link>, <xref ref-type="bibr" rid="pc.REF.eliason.2012.680">Eliason et al 2012</xref>]. Other clinical features can include pilosebaceous cysts (including steatocystoma and vellus hair cysts), oral leukokeratosis, follicular keratosis, and palmar keratoderma.</p>
        <p>Based on data from the International Pachyonychia Congenita Research Rregistry (IPCRR), a new classification for pachyonychia congenita based on the mutated gene was proposed at the 2010 IPC Symposium [<xref ref-type="bibr" rid="pc.REF.mclean.2011.1015">McLean et al 2011</xref>, <xref ref-type="bibr" rid="pc.REF.wilson.2011.1018">Wilson et al 2011</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>PC-K6a (caused by mutation of <italic toggle="yes">KRT6A</italic>)</p>
          </list-item>
          <list-item>
            <p>PC-K6b (caused by mutation of <italic toggle="yes">KRT6B</italic>)</p>
          </list-item>
          <list-item>
            <p>PC-K6c (caused by mutation of <italic toggle="yes">KRT6C</italic>)</p>
          </list-item>
          <list-item>
            <p>PC-K16 (caused by mutation of <italic toggle="yes">KRT16</italic>)</p>
          </list-item>
          <list-item>
            <p>PC-K17 (caused by mutation of <italic toggle="yes">KRT17</italic>)</p>
          </list-item>
        </list>
        <p>Note: For information on the old classification scheme see <xref ref-type="sec" rid="pc.Nomenclature">Nomenclature</xref>.</p>
        <sec id="pc.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>The predominant and most common clinical feature of PC is plantar pain associated with plantar keratoderma including callus with underlying blisters. While various types of hypertrophic nail dystrophy are common, signs in some affected individuals are limited to toenails, or to a few toenails or fingernails (<xref ref-type="table" rid="pc.T.international_pachyonychia_congenit">Table 2</xref>). See <xref ref-type="fig" rid="pc.F1">Figure 1</xref>.</p>
          <p>Other findings found in some types of PC:</p>
          <list list-type="bullet">
            <list-item>
              <p>Pilosebaceous cysts including widespread steatocystomas/steatocysts (benign lesions) and vellus hair cysts which usually develop at puberty and continue throughout adulthood</p>
            </list-item>
            <list-item>
              <p>Oral leukokeratosis and thickened nails (present at birth or by age 1 month) more commonly seen in PC-K6a</p>
            </list-item>
            <list-item>
              <p>Follicular keratoses on the trunk and extremities usually present by early childhood</p>
            </list-item>
            <list-item>
              <p>Palmoplantar hyperhydrosis (&#x0003c;50%)</p>
            </list-item>
            <list-item>
              <p>Natal or prenatal teeth (i.e., present at birth or by age 1 month) more commonly seen in PC-K17</p>
              <p>Of note, histologic, immunohistologic, or electron microscopic examination of the nails or skin from individuals with PC is not helpful in confirming the diagnosis of PC but can be performed to rule out other diagnoses.</p>
            </list-item>
            <list-item>
              <p>Family history consistent with autosomal dominant inheritance</p>
              <p>Of note, 60% of individuals with PC have inherited it from an affected parent and 40% are simplex cases (i.e., a single occurrence in a family). If the family history suggests autosomal recessive inheritance, a condition other than PC should be considered (see <xref ref-type="sec" rid="pc.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
            </list-item>
          </list>
        </sec>
        <sec id="pc.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>Identification of a heterozygous pathogenic variant in one of the five genes encoding keratin confirms the diagnosis of pachyonychia congenita (<xref ref-type="table" rid="pc.T.summary_of_molecular_genetic_testin">Table 1</xref>).</p>
          <p>Sequence analysis of these five genes identifies pathogenic variants in approximately 90% of individuals with clinically diagnosed PC [<xref ref-type="bibr" rid="pc.REF.smith.2005.21">Smith et al 2005</xref>, <xref ref-type="bibr" rid="pc.REF.liao.2007.199">Liao et al 2007</xref>, <xref ref-type="bibr" rid="pc.REF.wilson.2011.1018">Wilson et al 2011</xref>]. Note: In some laboratories, the highly conserved helix boundary domains, the site of the majority of pathogenic variants, are sequenced first; the remaining exons are sequenced as needed.</p>
          <p><bold>One approach to genetic testing</bold> is serial single gene molecular genetic testing (i.e., <italic toggle="yes">KRT6A,</italic>
<italic toggle="yes">KRT6B, KRT6C</italic>, <italic toggle="yes">KRT16,</italic> and <italic toggle="yes">KRT17</italic>) based on specific clinical features that are associated with each gene (<xref ref-type="table" rid="pc.T.international_pachyonychia_congenit">Table 2</xref>).</p>
          <p><bold>An alternative approach to genetic testing</bold> is use of a multi-gene panel that includes these five genes and other genes of interest (see <xref ref-type="sec" rid="pc.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          <table-wrap id="pc.T.summary_of_molecular_genetic_testin" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Pachyonychia Congenita (PC)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th>
                  <th id="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Classification</th>
                  <th id="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotype</th>
                  <th id="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="top" align="left" scope="col" rowspan="1" colspan="1">Proportion of PC Attributed to Mutation of This Gene</th>
                  <th id="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT6A</italic>
                  </td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">PC-K6a</td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">PC</td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">222/535 (42%)</td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_5" rowspan="5" valign="middle" align="left" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT6B</italic>
                  </td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">PC-K6b</td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">PC</td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">50/535 (9%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT6C</italic>
                  </td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">PC-K6c</td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">PC/FNEPPK&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">17/535 (3%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT16</italic>
                  </td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">PC-K16</td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">PC/FNEPPK&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">155/535 (29%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT17</italic>
                  </td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">PC-K17</td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">PC/SM&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_pc.T.summary_of_molecular_genetic_testin_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">91/535 (17%)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>PC = pachyonychia congenita</p>
              </fn>
              <fn>
                <p>FNEPPK = focal non-epidermolytic palmoplantar keratoderma</p>
              </fn>
              <fn>
                <p>SM = steatocystoma multiplex</p>
              </fn>
              <fn id="pc.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="pc" object-id="pc.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="pc.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="pc.TF.1.2">
                <label>2. </label>
                <p>Pathogenic variants in at least 535 individuals have been published to date [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.interfil.org/"><underline>Human Intermediate Filament Database</underline></ext-link>, <xref ref-type="bibr" rid="pc.REF.wilson.2011.1018">Wilson et al 2011</xref>].</p>
              </fn>
              <fn id="pc.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="pc.TF.1.4">
                <label>4. </label>
                <p>To date all pathogenic variants causing FNEPPK are in <italic toggle="yes">KRT16</italic> or <italic toggle="yes">KRT6C</italic> [<xref ref-type="bibr" rid="pc.REF.wilson.2010.425">Wilson et al 2010</xref>]. See <xref ref-type="sec" rid="pc.Genetically_Related_Allelic_Disorders">Genetically Related Disorders</xref> and <xref ref-type="sec" rid="pc.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
              </fn>
              <fn id="pc.TF.1.5">
                <label>5. </label>
                <p>To date all pathogenic variants causing SM (steatocystoma multiplex) are in <italic toggle="yes">KRT17.</italic> See <xref ref-type="sec" rid="pc.Genetically_Related_Allelic_Disorders">Genetically Related Disorders</xref>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="pc.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="pc.Clinical_Description">
          <title>Clinical Description</title>
          <p>Pachyonychia congenita (PC) is a combination of characteristics. The absence or presence of the condition as well as the age at onset varies according the gene that is mutated (see <xref ref-type="table" rid="pc.T.international_pachyonychia_congenit">Table 2</xref> for phenotypic features of PC). In all types of PC most characteristics are visible by age ten years [<xref ref-type="bibr" rid="pc.REF.shah.2014.146">Shah et al 2014</xref>]. The severity of findings differs both within a family and among families with the same pathogenic variant.</p>
          <table-wrap id="pc.T.international_pachyonychia_congenit" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>International Pachyonychia Congenita Research Registry (IPCRR) Data Summary as of 30 March 2014</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" colspan="4" valign="top" align="left" scope="colgroup" rowspan="1">Gene in which Mutation was Confirmed</th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT6A</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT6B</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT6C</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT16</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT17</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Total</th>
                </tr>
                <tr>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1" id="hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" colspan="4" valign="top" align="left" scope="colgroup" rowspan="1">Number Evaluated for Finding&#x000a0;<sup>1</sup></th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2" id="hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">222</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3" id="hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">50</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4" id="hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">17</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5" id="hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">155</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6" id="hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">91</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7" id="hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1">535</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" colspan="10" valign="top" align="left" scope="col" rowspan="1">
                    <bold>Toenails thickened</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">10 toenails</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">208<break/>(94%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">19<break/>(38%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">67<break/>(43%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">68<break/>(75%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">362<break/>(68%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">7-9 toenails</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(03%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">11<break/>(22%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">18<break/>(12%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(07%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">41<break/>(08%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">4-6 toenails</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">2<break/>(01%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">13<break/>(26%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(18%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">36<break/>(23%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">9<break/>(10%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">63<break/>(12%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">1-3 toenails</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(02%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(12%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">7<break/>(41%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">27<break/>(17%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">7<break/>(08%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">51<break/>(10%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">
                    <bold>Total w/toenails thickened</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"><bold>220</bold><break/>(99%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"><bold>49</bold><break/>(98%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"><bold>10</bold><break/>(59%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"><bold>148</bold><break/>(95%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"><bold>90</bold><break/>(99%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"><bold>517</bold><break/>(97%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" rowspan="4" valign="middle" colspan="3" align="left" scope="row">
                    <bold>Age at onset</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Birth - &#x0003c;1 yr</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">191<break/>(87%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">9<break/>(18%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(10%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">34<break/>(23%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">61<break/>(68%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">296<break/>(57%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">1-4 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">25<break/>(11%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">12<break/>(24%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">5<break/>(50%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">44<break/>(30%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">22<break/>(24%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">108<break/>(21%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">5-14 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(02%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">24<break/>(49%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(30%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">45<break/>(30%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(07%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">82<break/>(16%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x02265;15 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(08%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(10%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">25<break/>(17%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(01%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">31<break/>(06%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" colspan="10" align="left" scope="col" rowspan="1">
                    <bold>Fingernails thickened</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">10 fingernails</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">194<break/>(87%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(08%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">54<break/>(35%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">40<break/>(44%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">292<break/>(55%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">7-9 fingernails</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(03%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(06%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(04%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">11<break/>(12%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">26<break/>(05%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">4-6 fingernails</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">14<break/>(06%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">12<break/>(24%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">19<break/>(12%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">21<break/>(23%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">66<break/>(12%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">1-3 fingernails</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(03%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(12%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">15<break/>(10%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">7<break/>(08%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">34<break/>(06%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">
                    <bold>Total w/fingernails thickened</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"><bold>220</bold><break/>(99%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"><bold>25</bold><break/>(50%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"><bold>0</bold><break/>(00%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"><bold>94</bold><break/>(61%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"><bold>79</bold><break/>(87%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"><bold>418</bold><break/>(78%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" rowspan="4" valign="middle" colspan="2" align="left" scope="row">
                    <bold>Age at onset</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="2" align="left" rowspan="1">Birth - &#x0003c;1 yr</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">194<break/>(88%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(16%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">26<break/>(28%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">56<break/>(71%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">280<break/>(67%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">1-4 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">23<break/>(10%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(24%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">30<break/>(32%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">18<break/>(23%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">77<break/>(18%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">5-14 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(01%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">11<break/>(44%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">18<break/>(19%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(05%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">36<break/>(09%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">&#x02265;15 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(00.5%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(16%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">20<break/>(21%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(01%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">26<break/>(06%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" colspan="10" valign="top" align="left" scope="col" rowspan="1">
                    <bold>Plantar keratoderma&#x000a0;<sup>2</sup></bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">Always</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">192<break/>(86%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">48<break/>(96%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">16<break/>(94%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">153<break/>(99%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">61<break/>(67%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">470<break/>(88%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">Sometimes</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(01%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">9<break/>(10%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">12<break/>(02%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">Seldom</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(01%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(03%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(01%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">
                    <bold>Total w/plantar keratoderma</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"><bold>198</bold><break/>(89%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"><bold>48</bold><break/>(96%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"><bold>16</bold><break/>(94%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"><bold>153</bold><break/>(99%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"><bold>73</bold><break/>(80%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"><bold>488</bold><break/>(91%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Age at onset</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="3" align="left" rowspan="1">Birth - &#x0003c;1 yr</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">26<break/>(13%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(02%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(06%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">12<break/>(08%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">11<break/>(15%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">51<break/>(10%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">1-4 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">119<break/>(60%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">17<break/>(35%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">7<break/>(44%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">85<break/>(56%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">26<break/>(36%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">254<break/>(52%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">5-14 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">51<break/>(26%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">29<break/>(60%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">8<break/>(50%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">49<break/>(32%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">29<break/>(40%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">166<break/>(34%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">&#x02265;15 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">2<break/>(01%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(02%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">7<break/>(05%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">7<break/>(10%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">17<break/>(03%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" colspan="10" valign="top" align="left" scope="col" rowspan="1">
                    <bold>Plantar pain w/plantar keratoderma&#x000a0;<sup>3</sup></bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">Often require medication for pain</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">49<break/>(25%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">8<break/>(17%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(19%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">48<break/>(31%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">14<break/>(19%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">122<break/>(25%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">Very painful, but do not use medication</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">83<break/>(42%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">24<break/>(50%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">10<break/>(63%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">74<break/>(48%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">23<break/>(32%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">214<break/>(44%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">Somewhat painful</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">59<break/>(30%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">16<break/>(33%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(19%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">27<break/>(18%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">28<break/>(38%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">133<break/>(27%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_1" valign="middle" colspan="4" align="left" scope="row" rowspan="1">
                    <bold>Total w/plantar keratoderma / pain</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"><bold>191</bold><break/>(96%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"><bold>48</bold><break/>(100%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"><bold>16</bold><break/>(100%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"><bold>149</bold><break/>(97%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"><bold>65</bold><break/>(89%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_1_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"><bold>469</bold><break/>(96%)</td>
                </tr>
              </tbody>
            </table>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1" colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Gene in which Mutation was Confirmed</th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT6A</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT6B</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT6C</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT16</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <italic toggle="yes">KRT17</italic>
                  </th>
                  <th id="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Total</th>
                </tr>
                <tr>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1" id="hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">Number Evaluated for Finding</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2" id="hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">222</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3" id="hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">50</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4" id="hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">17</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5" id="hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">155</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6" id="hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">91</th>
                  <th headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7" id="hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1">535</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" colspan="9" align="left" scope="col" rowspan="1">
                    <bold>Palmar keratoderma&#x000a0;<sup>2</sup></bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">Always</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">62<break/>(28%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">8<break/>(16%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(06%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">99<break/>(64%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">15<break/>(16%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">185<break/>(35%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">Sometimes</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">21<break/>(09%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">5<break/>(10%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">11<break/>(07%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">13<break/>(14%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">50<break/>(09%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">Seldom</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">38<break/>(17%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">7<break/>(14%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">2<break/>(12%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">13<break/>(08%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">19<break/>(21%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">79<break/>(15%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">
                    <bold>Total w/palmar keratoderma</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1"><bold>121</bold><break/>(55%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1"><bold>20</bold><break/>(40%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1"><bold>3</bold><break/>(18%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1"><bold>123</bold><break/>(79%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1"><bold>47</bold><break/>(52%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1"><bold>314</bold><break/>(59%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" rowspan="5" valign="middle" colspan="2" align="left" scope="row">
                    <bold>Age at onset</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" align="left" rowspan="1" colspan="1">See footnote 4</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>121</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>15</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>2</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>115</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>42</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>295</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Birth - &#x0003c;1 yr</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">17<break/>(14%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">9<break/>(08%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">8<break/>(19%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">34<break/>(12%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">1-4 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">38<break/>(31%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(07%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">40<break/>(35%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">7<break/>(17%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">86<break/>(29%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">5-14 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">51<break/>(42%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">8<break/>(53%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">2<break/>(100%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">46<break/>(40%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">18<break/>(43%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">125<break/>(42%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x02265;15 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">15<break/>(12%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(40%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">20<break/>(17%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">9<break/>(21%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">50<break/>(17%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" colspan="9" align="left" scope="col" rowspan="1">
                    <bold>Oral leukokeratosis</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">
                    <bold>Total w/oral leukokeratosis</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1"><bold>195</bold><break/>(88%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1"><bold>15</bold><break/>(30%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1"><bold>3</bold><break/>(18%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1"><bold>64</bold><break/>(41%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1"><bold>25</bold><break/>(27%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1"><bold>302</bold><break/>(56%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" rowspan="5" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Age at onset</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="2" align="left" rowspan="1">See footnote 4</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>155</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>15</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>1</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>47</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>18</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">
                    <bold>236</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">Birth - &#x0003c;1 yr</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">120<break/>(77%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">3<break/>(20%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(100%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">17<break/>(36%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(33%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">147<break/>(62%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">1-4 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">17<break/>(11%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">1<break/>(07%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">5<break/>(11%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(22%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">27<break/>(11%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">5-14 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">13<break/>(08%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">6<break/>(40%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">9<break/>(19%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(22%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">32<break/>(14%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">&#x02265;15 yrs</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">5<break/>(03%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">5<break/>(33%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">16<break/>(34%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(22%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">30<break/>(13%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" colspan="9" align="left" scope="col" rowspan="1">
                    <bold>Additional findings</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">
                    <bold>Cysts</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">151<break/>(68%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">36<break/>(72%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">4<break/>(24%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">40<break/>(26%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">84<break/>(92%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">315<break/>(59%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">
                    <bold>Follicular hyperkeratosis</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">135<break/>(61%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">23<break/>(46%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">23<break/>(15%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">63<break/>(69%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">244<break/>(46%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_1 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_1" valign="middle" colspan="3" align="left" scope="row" rowspan="1">
                    <bold>Natal or prenatal teeth</bold>
                  </td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_2 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_2" valign="middle" align="left" rowspan="1" colspan="1">5<break/>(02%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_3 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_3" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_4 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_4" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_5 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_5" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_6 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_6" valign="middle" align="left" rowspan="1" colspan="1">69<break/>(76%)</td>
                  <td headers="hd_h_pc.T.international_pachyonychia_congenit_1_2_1_7 hd_h_pc.T.international_pachyonychia_congenit_1_2_2_7" valign="middle" align="left" rowspan="1" colspan="1">74<break/>(14%)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="pc.TF.2.1">
                <label>1. </label>
                <p>Data include 535 individuals with genetically confirmed pachyonychia congenita.</p>
              </fn>
              <fn id="pc.TF.2.2">
                <label>2. </label>
                <p>Always = symptoms never completely go away</p>
              </fn>
              <fn>
                <p>Sometimes = feet/hands clear up completely at times</p>
              </fn>
              <fn>
                <p>Seldom = feet/hands are usually clear/symptoms</p>
              </fn>
              <fn id="pc.TF.2.3">
                <label>3. </label>
                <p>By age &#x02264;10 years</p>
              </fn>
              <fn id="pc.TF.2.4">
                <label>4. </label>
                <p>Total number of persons with indicated finding for whom age at onset was identified</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Hypertrophic nail dystrophy,</bold> the predominant clinical feature of PC, is typically noted within the first few months of life, though in rare cases it presents later. The nail dystrophy appears to fall into two phenotypes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Nails that grow to full length and have an upward slant caused by the prominent distal hyperkeratosis (often with an accentuated curvature of the nail)</p>
            </list-item>
            <list-item>
              <p>Nails that have a nail plate that terminates prematurely leaving a gently sloping distal region of hyperkeratosis and exposed distal finger tip</p>
            </list-item>
          </list>
          <p><bold>Focal palmoplantar keratoderma</bold> usually presents during the first few years of life when a child starts bearing weight and walking. Blisters develop beneath the keratoderma resulting in intense pain. For many individuals, the blisters and constant foot pain are more severe in warmer weather than cooler weather. The pain associated with plantar focal blistering may require the use of crutches, canes, or wheelchairs. Rarely, keratosis palmoplantaris transgrediens (the contiguous extension of hyperkeratosis beyond the palmar and/or plantar skin) is present.</p>
          <p><bold>Oral leukokeratosis</bold> (thickened white patches on the tongue and cheek) is often present. In babies, oral leukokeratosis can be misdiagnosed as <italic toggle="yes">Candida albicans</italic> and may cause difficulty in sucking.</p>
          <p><bold>Follicular keratosis,</bold> usually on the elbows, knees or trunk, occurs in some persons. It is more prevalent in late childhood and teenage years and becomes less problematic in adults.</p>
          <p><bold>Pilosebaceous cysts including widespread steatocystomas/steatocysts (benign lesions) and vellus hair cysts.</bold> Cysts may increase in number at puberty. Early onset has been reported [<xref ref-type="bibr" rid="pc.REF.feng.2003.452">Feng et al 2003</xref>] and is recorded in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.pachyonychia.org/">International Pachyonychia Congenita Research Registry</ext-link> (IPCRR).</p>
          <p><bold>Natal teeth or prenatal teeth.</bold> Although some individuals have a few prenatal or natal teeth, this finding is not consistently present even within the same family [<xref ref-type="bibr" rid="pc.REF.leachman.2005.3">Leachman et al 2005</xref>]. Natal teeth are usually associated with pathogenic variants in <italic toggle="yes">KRT17</italic>.</p>
          <p>Primary and secondary dentition is normal.</p>
          <p><bold>Other findings</bold> that may occur:</p>
          <list list-type="bullet">
            <list-item>
              <p>Excessive sweating of the palms and soles (palmoplantar hyperhydrosis) observed in approximately 50% of individuals</p>
            </list-item>
            <list-item>
              <p>Axillary and inguinal cyst formation</p>
            </list-item>
            <list-item>
              <p>Excessive production of waxy material in the ear</p>
            </list-item>
            <list-item>
              <p>Severe and unexplained ear pain</p>
            </list-item>
            <list-item>
              <p>Hoarseness (laryngeal involvement), reported primarily in young children. Although rare, laryngeal involvement may cause life-threatening respiratory distress.</p>
            </list-item>
            <list-item>
              <p>Angular cheilitis (inflammation and fissuring at the angles of the mouth) which is sometimes secondarily infected</p>
            </list-item>
            <list-item>
              <p>Paronychia with pronounced edema (and occasional blister formation) under the nails; can exhibit lymphatic extension and can sometimes be caused by infection</p>
            </list-item>
          </list>
          <p>Primary and secondary dentition is normal.</p>
          <p><bold>Other findings</bold> that may occur:</p>
          <list list-type="bullet">
            <list-item>
              <p>Leukokeratosis with laryngeal involvement may; be present in infants and children with PC-K6a. It usually has no ill effect other than a hoarse voice. Although operative intervention is generally not indicated, rare cases of severe respiratory distress requiring intervention have been reported.</p>
            </list-item>
            <list-item>
              <p>Angular cheilitis (inflammation and fissuring at the angles of the mouth), which is sometimes secondarily infected</p>
            </list-item>
            <list-item>
              <p>Paronychia with pronounced edema (and occasional blister formation) under the nails; when associated with bacterial infection, lymphangitis may be present.</p>
            </list-item>
          </list>
        </sec>
        <sec id="pc.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Based on data on 535 individuals with PC in the IPCRR, clear genotype-phenotype correlations are evident [<xref ref-type="bibr" rid="pc.REF.spaunhurst.2012.875">Spaunhurst et al 2012</xref>] (see <xref ref-type="table" rid="pc.T.international_pachyonychia_congenit">Table 2</xref>).</p>
          <p>Even within a family, the same pathogenic variant may result in variable severity (e.g., mild vs severe keratoderma).</p>
          <p>In the following instances, the phenotype may vary in individuals with the same pathogenic variant:</p>
          <list list-type="bullet">
            <list-item>
              <p>The same <italic toggle="yes">KRT17</italic> pathogenic variant in the highly conserved helix initiation motif has been observed in classic PC and in the milder variant SM with few or no nail changes. The modifying factors responsible for this variable expressivity are not known.</p>
            </list-item>
            <list-item>
              <p>In a few reports of late-onset PC, pathogenic variants have been identified outside the helix boundary and some have questioned whether the location of the pathogenic variant affects the age at onset. However, the ages in these cases are the expected ages at onset for the particular type of PC and should likely not be referred to as &#x02018;late-onset.&#x02019;</p>
            </list-item>
          </list>
        </sec>
        <sec id="pc.Penetrance">
          <title>Penetrance</title>
          <p>Within families studied to date, inheritance of a pathogenic variant is uniformly associated with some manifestation of disease, suggesting that penetrance is 100%.</p>
        </sec>
        <sec id="pc.Nomenclature">
          <title>Nomenclature</title>
          <p>The classification suggested for PC prior to the identification of the genetic basis of the disease was based solely on clinical findings. Historically, the two major subtypes of PC were based on subtle variable phenotypic features (primarily on the presence or absence of pilosebaceous cysts and natal or prenatal teeth) [<xref ref-type="bibr" rid="pc.REF.leachman.2005.3">Leachman et al 2005</xref>, <xref ref-type="bibr" rid="pc.REF.liao.2007.199">Liao et al 2007</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>PC-1 (Jadassohn-Lewandowski syndrome)</p>
            </list-item>
            <list-item>
              <p>PC-2 (Jackson-Lawler syndrome)</p>
            </list-item>
          </list>
          <p>With detailed clinical histories and pathogenic variants identified in an increasing number of people with PC, it became clear that the older classification of PC-1 and PC-2 was not applicable to the broader population of individuals with PC. Subsequently, a more rational and useful classification, based on the mutated gene and International Pachyonychia Research Registry (IPCRR) data on nearly 400 persons, was proposed at the 2010 International Pachyonychia Congenita (IPCC) Symposium. See <xref ref-type="sec" rid="pc.Diagnosis">Diagnosis</xref>.</p>
        </sec>
        <sec id="pc.Prevalence">
          <title>Prevalence</title>
          <p>The rarity of PC makes it difficult to accurately assess its prevalence. Pathogenic variants in individuals from at least 325 families have been published to date [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.interfil.org/"><underline>Human Intermediate Filament Database</underline></ext-link>, <xref ref-type="bibr" rid="pc.REF.szeverenyi.2008.351">Szeverenyi et al 2008</xref>, <xref ref-type="bibr" rid="pc.REF.wilson.2013.58">Wilson et al 2013</xref>, <xref ref-type="bibr" rid="pc.REF.wilson.2014.343">Wilson et al 2014</xref>].</p>
          <p>The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.pachyonychia.org/">International PC Research Registry</ext-link> has identified 535 individuals with genetically confirmed PC and 128 with a clinical phenotype of PC who have other disorders. Approximately 600 individuals with some features of PC have not yet undergone genetic testing.</p>
        </sec>
      </sec>
      <sec id="pc.Genetically_Related_Allelic_Disorders">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">KRT6A</italic>, <italic toggle="yes">KRT6B</italic>.</bold> No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in these genes.</p>
        <p><bold><italic toggle="yes">KRT6C.</italic></bold> Focal non-epidermolytic palmoplantar keratoderma (FNEPPK), defined as keratoderma of varying severity that may occur on the palms and soles with no (or very mild) nail dystrophy, occurs in association with pathogenic variants in <italic toggle="yes">KRT6C</italic> [<xref ref-type="bibr" rid="pc.REF.wilson.2010.425">Wilson et al 2010</xref>].</p>
        <p><bold><italic toggle="yes">KRT17.</italic></bold> Steatocystoma multiplex (SM), defined as widespread steatocystomas (benign lesions) that can develop at puberty with little or no nail involvement or palmoplantar keratoderma, occurs in association with pathogenic variants in <italic toggle="yes">KRT17</italic>. Comedone-like cysts may be found in children particularly in the axillae.</p>
        <p><bold><italic toggle="yes">KRT16.</italic></bold> Focal non-epidermolytic palmoplantar keratoderma (FNEPPK), defined as keratoderma of varying severity that may occur on the palms and soles with no/very mild nail dystrophy, occurs in association with pathogenic variants of <italic toggle="yes">KRT16</italic> [<xref ref-type="bibr" rid="pc.REF.fu.2011.1025">Fu et al 2011</xref>].</p>
      </sec>
      <sec id="pc.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Onychomycosis.</bold> Although the hyperkeratotic nail thickening seen in pachyonychia congenita (PC) may be mistaken for onychomycosis, dermatophytic infections do not affect all finger and toenails particularly at an early age. In the rare conditions of autoimmune endocrinopathy-candidiasis-ectodermal dystrophy (APECED) and systemic mucocutaneous candidosis, all nails may be affected.</p>
        <p><bold>Oral leukokeratosis</bold> together with nail dystrophy is often an indication of pachyonychia congenita and may be mistaken for <italic toggle="yes">Candida albicans</italic> (thrush), white sponge nevus and/or leukoplakia.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter"><bold>Epidermolysis bullosa simplex</bold></related-object>
<bold>(EBS)</bold> or other palmoplantar keratodermas can result in a similar pattern of plantar blister formation or hyperkeratosis, respectively; however, they do not share the characteristic nail changes of PC.</p>
        <p>Note: EBS may be incorrectly diagnosed in young children with PC because they have a greater tendency toward blister formation and lesser tendency toward keratoderma.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="ed2" document-type="chapter"><bold>Clouston syndrome</bold></related-object><bold>,</bold> caused by mutation of <italic toggle="yes">GJB6</italic>, the gene encoding the gap junction protein connexin 30, can also mimic PC. Alopecia does not typically occur in PC but is a relatively common feature of Clouston syndrome.</p>
        <p><bold>Nonsyndromic congenital nail disorder 10</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/614157">OMIM</ext-link>) without the associated palmoplantar keratoderma or other features of PC can be confused with PC. This is an autosomal recessive disorder caused by biallelic pathogenic variants in <italic toggle="yes">FZD6,</italic> encoding frizzled 6 [<xref ref-type="bibr" rid="pc.REF.wilson.2013.58">Wilson et al 2013</xref>].</p>
        <p><bold>Familial onychogryphosis</bold> without the associated palmoplantar keratoderma or other features of PC can be confused with PC. Individuals who have nail findings only are unlikely to demonstrate mutation in one of the PC keratins.</p>
        <p><bold>Twenty-nail dystrophy</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/161050">OMIM</ext-link>) may occur without keratoderma or other associated changes. Autosomal dominant inheritance has been described.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="dkc" document-type="chapter"><bold>Dyskeratosis congenita</bold></related-object> manifests with features overlapping with PC including nail dystrophy, PPK, hyperhidrosis, and oral leukoplakia. Distinctive features include reticulate hyperpigmentation, skin tumors, and hematologic manifestation.</p>
        <p><bold>Palmoplantar keratoderma striata (PPKS1)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/148700">OMIM</ext-link>), caused by pathogenic variants in <italic toggle="yes">DSG1</italic>, can be confused with focal non-epidermolytic palmoplantar keratoderma (FNEPPK). However, pain is typically either absent or less significant in PPKS1 than in FNEPPK or PC.</p>
        <p><bold>Punctate PPK type 1</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/148600">OMIM</ext-link>), caused by pathogenic variants in <italic toggle="yes">AAGAB</italic>, can be painful and focal (due to coalescence of lesions) [<xref ref-type="bibr" rid="pc.REF.pohler.2012.1272">Pohler et al 2012</xref>].</p>
        <p><bold>Olmsted syndrome</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/614594">OMIM</ext-link>) is charactereized by painful palmoplantar keratoderma that may occur with additional features including periorificial keratotic plaques and sometimes constricting digital bands on hands and feet that result in spontaneous amputation, mutilating PPK, alopecia, nail dystrophy and itching of lesions. It is caused by pathogenic variants in <italic toggle="yes">TRPV3</italic> [<xref ref-type="bibr" rid="pc.REF.lin.2012.558">Lin et al 2012</xref>].</p>
      </sec>
      <sec id="pc.Management">
        <title>Management</title>
        <sec id="pc.Evaluations_Following_Initial_Diagnos">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with pachyonychia congenita, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Thorough clinical examination to assess each affected area. These will vary based on the specific gene involved (see <xref ref-type="table" rid="pc.T.international_pachyonychia_congenit">Table 2</xref>) and may need to be repeated once genetic testing is completed in order to fully understand the phenotype of the affected individual.</p>
            </list-item>
            <list-item>
              <p>Medical history to determine what features actually are troubling the patient</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="pc.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Preliminary treatment guidelines have been published [<xref ref-type="bibr" rid="pc.REF.goldberg.2014.279">Goldberg et al 2014</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/doi/10.1111/jdv.12098/full">full text</ext-link>) and continue to be refined.</p>
          <p>The current treatment modalities primarily center on symptomatic relief of pain, hygienic grooming practices including paring of hyperkeratotic areas, treatment of secondary infection when indicated, and use of various walking aids, including wheelchairs, crutches and canes.</p>
          <p><bold>Palmoplantar keratoderma.</bold> Frequent grooming of the feet is essential and includes paring down the hyperkeratotic areas. However, trimming too aggressively can greatly increase pain. Some find it helpful to soak the feet prior to the paring. The surface of the skin and the instruments used should be clean to avoid infection. Blisters should be punctured with a sterile needle, the fluid drained, and the blister roof left in place until it dries and is shed away.</p>
          <p>Special orthotics or insoles, wicking socks, ventilated footwear or cushioned footwear can help to lessen the pain although pain varies from day to day and at times can be intense even at rest.</p>
          <p>Maintaining ideal body weight can be a factor in reducing the hyperkeratosis and pain. Limiting walking or standing can help to reduce trauma and slightly diminish the resulting blisters, callus, and pain.</p>
          <p>Topical therapies to remove the hyperkeratosis:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Emollients</bold> such as Vaseline<sup>&#x000ae;</sup> or lanolin-containing products are frequently used. Note: Creams and lotions containing keratolyics such as urea, lactic acid, salicylic acid, or propylene glycol have little effect, with some reporting negative side effects. Occlusive ointments are often poorly tolerated.</p>
            </list-item>
            <list-item>
              <p><bold>Oral retinoids,</bold> while reducing the keratoderma, do not affect the underlying blistering and fragility of the skin and sometimes increase the pain. Careful regulation of the dosage is necessary [<xref ref-type="bibr" rid="pc.REF.gruber.2012.e193">Gruber et al 2012</xref>].</p>
            </list-item>
          </list>
          <p><bold>Nail dystrophy.</bold> Thickened nails are not typically painful, but become so when infected or traumatized. An effective tool for very thick nails and for children is a guillotine-type pet nail clipper which places no pressure on the nails. Other tools frequently used are razor or surgical blades or sanders such as a Dremel<sup>&#x000ae;</sup> tool.</p>
          <p>If bacterial or fungal infections occur, systemic antibiotics or antifungals are indicated.</p>
          <p>Particularly troublesome nails can be successfully removed surgically; however, few patients have had this procedure and in most cases &#x02013; regardless of the specific pathogenic variant &#x02013; the nails have re-grown.</p>
          <p><bold>Oral leukokeratosis.</bold> Good oral hygiene and frequent gentle brushing with a toothbrush can significantly improve the appearance of the thick, white patches on the tongue and oral mucosa; however, if done too vigorously, brushing may also traumatize the mucosa resulting in reactive hyperkeratosis.</p>
          <p>Some individuals have reported reduction of the leukokeratosis in response to oral antibiotics, suggesting a possible bacterial contribution; more likely, improvement may be a response to the anti-inflammatory properties of the antibiotics.</p>
          <p><bold>Follicular hyperkeratosis.</bold> Especially bothersome for children and teens, this finding can be treated with alpha-hydroxy acid creams or lotions or keratolytic emollients; however, these treatments may not be especially effective for PC. The use of emollients such as Vaseline<sup>&#x000ae;</sup> or lanolin-containing products is reported to be as effective.</p>
          <p><bold>Leukokeratosis with laryngeal involvement</bold>. Reported only in children with PC-K6a, respiratory insufficiency can on occasion become life-threatening, requiring emergent surgical intervention to re-establish the airway. The surgical procedures are repeated as necessary to maintain an open airway; however, surgical procedures to the larynx aimed at improving hoarseness should be avoided as they may tend to worsen the condition.</p>
          <p><bold>Cysts.</bold> Steatocystoma multiplex and other pilosebaceous cysts can be treated by incision with a number 11 blade and subsequent expression of the contents of the cyst (&#x0201c;incision and drainage&#x0201d;). Oral antibiotics may be indicated in the case of secondary infection. A culture should be obtained if infection is a consideration. Intralesional injection of steroid (e.g., triamcinolone) may reduce inflammation of the area if infection is not suspected. If necessary, cysts can be excised.</p>
          <p><bold>Failure to thrive.</bold> Poor feeding in infancy has been reported to be ameliorated by the use of a soft nipple with an enlarged opening to reduce the sucking required. All cases of &#x02018;failure to thrive&#x02019; and poor feeding in infancy have been found to be type PC-K6a.</p>
        </sec>
        <sec id="pc.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>There are no known effective measures to prevent the primary manifestations of PC. Consistent, regular care of the conditions is necessary. Reduction of trauma, friction, and shear forces to the skin and nails does little to reduce symptoms.</p>
        </sec>
        <sec id="pc.Prevention_of_Secondary_Complications">
          <title>Prevention of Secondary Complications</title>
          <p>Infection of the skin and nails following grooming or trauma is the most common secondary complication seen in PC.</p>
          <list list-type="bullet">
            <list-item>
              <p>Pre- and post-grooming hygiene and use of clean instruments minimizes this complication.</p>
            </list-item>
            <list-item>
              <p>Antibiotics may be indicated when infection occurs.</p>
            </list-item>
            <list-item>
              <p>A simple &#x02018;bleach bath&#x02019; regimen using a mild bleach solution can help prevent infections.</p>
            </list-item>
          </list>
        </sec>
        <sec id="pc.Surveillance">
          <title>Surveillance</title>
          <p>In general, individuals with PC have no known associated systemic diseases or predispositions that require routine surveillance.</p>
        </sec>
        <sec id="pc.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Some report that higher temperatures and higher humidity worsen the condition.</p>
        </sec>
        <sec id="pc.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Molecular genetic testing of at-risk relatives in a family with PC is not indicated because the phenotype is readily observed from a young age and no interventions can prevent the development of manifestations or reduce their severity.</p>
          <p>See <xref ref-type="sec" rid="pc.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="pc.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Increased risk to the fetus during pregnancy has not been reported.</p>
          <p>For a pregnant woman with PC, weight gain (increasing stress on the plantar surface) or altered hormonal environment during pregnancy may worsen the painful plantar keratoderma.</p>
        </sec>
        <sec id="pc.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>A study is underway to determine whether any specific procedures make a difference in nail regrowth for PC</p>
          <p>In 2014, a Phase 1b clinical trial sponsored by PC Project and TransDerm is underway using topical sirolimus. This 15-patient study is being conducted by Joyce Teng at Stanford University. Background research for this trial was previously published [<xref ref-type="bibr" rid="pc.REF.hickerson.2009.82">Hickerson et al 2009</xref>].</p>
          <p>A study is underway to determine whether any specific procedures make a difference in nail regrowth for PC (2014).</p>
          <p>siRNA can selectively block expression of a specific K6a pathogenic variant [<xref ref-type="bibr" rid="pc.REF.hickerson.2008.594">Hickerson et al 2008</xref>, <xref ref-type="bibr" rid="pc.REF.leachman.2008.151">Leachman et al 2008</xref>]. The siRNA trial included treatment of a single individual with a specific <italic toggle="yes">KRT6A</italic> pathogenic variant in a dose-escalation trial of an siRNA directed against the p.Asn171Lys mutated allele [<xref ref-type="bibr" rid="pc.REF.leachman.2010.442">Leachman et al 2010</xref>].</p>
          <p>Botulinum toxin has been used in several patients [<xref ref-type="bibr" rid="pc.REF.swartling.2006.763">Swartling &#x00026; Vahlquist 2006</xref>, <xref ref-type="bibr" rid="pc.REF.swartling.2010.1072">Swartling et al 2010</xref>]. In addition to these published investigations, a number of individuals have been treated. A proposal is now being prepared for a unified study using botulinum toxin on persons with confirmed PC. No further information has been developed on topical botulinum toxin although this approach is of interest.</p>
          <p>Several persons have been treated with statins. The results from studies are mixed. Further research is being conducted and additional animal testing is proposed [<xref ref-type="bibr" rid="pc.REF.zhao.2011.1045">Zhao et al 2011</xref>].</p>
          <p>Other therapies currently under investigation include anti-TNF biologics, duloxetine or duloxetine and a tricyclic combination, gabapentin, topical gabapentin, and capsaicin injections.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/"><underline>ClinicalTrials.gov</underline></ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="pc.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="pc.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Pachyonychia congenita (PC) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="pc.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Up to 60% of individuals diagnosed with pachyonychia congenita have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with pachyonychia congenita may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is approximately 40%. Of these, some may be novel pathogenic variants while others may be recurrent pathogenic variants identified in other families.</p>
            </list-item>
            <list-item>
              <p>Recommendation for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant is complete clinical examination by a dermatologist to confirm the lack of phenotype. If there are no phenotypic signs, no genetic testing is necessary.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk of having other affected children depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband is low, but greater than that of the general population because of the (theoretic, but unlikely) possibility of germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>The incidence of germline mosaicism is not known, but is extremely rare. Out of 535 cases, a single case of germline mosaicism (.001%) has been reported for PC [<xref ref-type="bibr" rid="pc.REF.pho.2011.1077">Pho et al 2011</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with pachyonychia congenita has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members may be affected and at risk of having affected children.</p>
        </sec>
        <sec id="pc.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>Because PC is a very rare disorder, affected individuals and families often feel completely isolated. Connecting affected individuals and families to the PC patient advocacy group (see <xref ref-type="sec" rid="pc.Resources">Resources</xref>), which offers many different support services, can often be extremely valuable [<xref ref-type="bibr" rid="pc.REF.schwartz.2013.42">Schwartz et al 2013</xref>].</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, the variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="pc.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diganosis are possible options.</p>
        </sec>
      </sec>
      <sec id="pc.Resources">
        <title>Resources</title>
      </sec>
      <sec id="pc.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="pc.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Keratins form a cytoskeletal intermediate filament network within all epithelial cells. Epithelia in different body regions utilize a range of different keratins. Keratins associated with PC are constitutively expressed in the nail, palmoplantar skin, oral mucosa, and hair. Thus, mutation of the genes encoding these keratins leads to pathology in these major body sites.</p>
          <p>The majority of the pathogenic variants causing PC are in the highly conserved helix boundary domains at either end of the rod domain (see <xref ref-type="fig" rid="pc.F2">Figure 2</xref>), consistent with the location of pathogenic variants in most other keratin disorders [<xref ref-type="bibr" rid="pc.REF.wilson.2011.1018">Wilson et al 2011</xref>]. A genotype/phenotype correlation is observed in the keratin disorder <related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter">epidermolysis bullosa simplex</related-object> (EBS), in which the more severe pathogenic variants occur in the helix boundary domains and those causing a milder phenotype occur within or outside these regions. So far, this has not been observed in PC. It could be that pathogenic variants in these less conserved regions in <italic toggle="yes">KRT6A</italic>, <italic toggle="yes">KRT6B</italic>, <italic toggle="yes">KRT6C</italic>, <italic toggle="yes">KRT16</italic>, or <italic toggle="yes">KRT17</italic> are in general not severe enough to produce a clinical phenotype.</p>
          <p>A schematic representation of the protein domain organization of each of the five keratins associated with PC is shown (K6a, K6b, K6c, K16, and K17) in <xref ref-type="fig" rid="pc.F2">Figure 2</xref>.</p>
          <p>Pathogenic variants in at least 325 families have been published to date [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.interfil.org/"><underline>Human Intermediate Filament Database</underline></ext-link>, <xref ref-type="bibr" rid="pc.REF.wilson.2013.58">Wilson et al 2013</xref>, <xref ref-type="bibr" rid="pc.REF.wilson.2014.343">Wilson et al 2014</xref>] (see <xref ref-type="table" rid="pc.T.selected_krt6a_pathogenic_variants">Table 3</xref>).</p>
          <p>A number of the pathogenic variants are recurrent but others are family specific. More than 100 different pathogenic variants have been identified; the majority are found in or near the helix initiation motif (shaded red; see <xref ref-type="fig" rid="pc.F2">Figure 2</xref>) in the 1A domain or the helix termination motif (shaded red) at the end of the 2B domain. The domains shown include the variable domains V1 and V2, homology subdomains H1 and H2, and the coiled coil domains 1A, 1B, 2A, and 2B, separated by non-helical linkers L1, L12, and L2.</p>
          <sec id="pc.KRT6A">
            <title>
              <italic toggle="yes">KRT6A</italic>
            </title>
            <p><bold>Gene structure.</bold> The cDNA comprises 2450 bp in nine exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pc" object-id="pc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> The majority of pathogenic variants are heterozygous missense variants; in some individuals, small in-frame deletions/insertions and splice site and nonsense variants have been reported. Most pathogenic variants occur in the highly conserved helix boundary motif domains located at either end of the alpha-helical keratin rod domain. There are a number of recurrent pathogenic variants; the major ones for PC-K6a, located at Asn171, are either a single amino-acid deletion c.516_518del or a missense variant affecting the neighboring amino acid residue Asn172 (<xref ref-type="table" rid="pc.T.selected_krt6a_pathogenic_variants">Table 3</xref>).</p>
            <table-wrap id="pc.T.selected_krt6a_pathogenic_variants" position="anchor" orientation="portrait">
              <label>Table 3. </label>
              <caption>
                <p>Selected <italic toggle="yes">KRT6A</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.511A&#x0003e;G</td>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn171Asp</td>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_005554.3">
                        <underline>NM_005554.3</underline>
                      </ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_005545.1">
                        <underline>NP_005545.1</underline>
                      </ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.511A&#x0003e;T</td>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn171Tyr</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.512A&#x0003e;G</td>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn171Ser</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.513C&#x0003e;A</td>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn171Lys</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.516_518del<break/>(514_516delAAC)</td>
                    <td headers="hd_h_pc.T.selected_krt6a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn172del</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic>&#x000a0;follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature. 1. Variant designation that does not conform to current naming conventions</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The protein, keratin, type II cytoskeletal 6A (K6a keratin), consists of 564 amino acids. Keratins form a cytoskeletal intermediate filament network within all epithelial cells.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p>
          </sec>
          <sec id="pc.KRT6B">
            <title>
              <italic toggle="yes">KRT6B</italic>
            </title>
            <p><bold>Gene structure.</bold> The cDNA comprises 2331 bp in nine exons (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/119703752"><underline>NM_005555.3</underline></ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pc" object-id="pc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> The pathogenic variants reported to date are heterozygous missense variants or small in-frame deletion variants in either the highly conserved helix initiation or helix termination domains.</p>
            <p><bold>Normal gene product.</bold> The protein, keratin, type II cytoskeletal 6B (K6b keratin), consists of 564 amino acids. Keratins form a cytoskeletal network within all epithelial cells.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p>
            <p>
              <bold>
                <italic toggle="yes">KRT6C</italic>
              </bold>
            </p>
            <p><bold>Gene structure.</bold> The cDNA comprises 2345 bp in nine exons (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucleotide&#x00026;val=155969696"><underline>NM_173086.4</underline></ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pc" object-id="pc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> The pathogenic variants reported to date are heterozygous missense variants or small in-frame deletion variants in regions encoding either the highly conserved helix initiation or helix termination domains.</p>
            <p><bold>Normal gene product.</bold> The protein, keratin, type II cytoskeletal 6C (K6c keratin), consists of 564 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_775109.2">NP_775109.2</ext-link>). Keratins form a cytoskeletal network within all epithelial cells.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p>
          </sec>
          <sec id="pc.KRT16">
            <title>
              <italic toggle="yes">KRT16</italic>
            </title>
            <p><bold>Gene structure.</bold> The cDNA comprises 1720 bp in eight exons (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/163659905"><underline>NM_005557.3</underline></ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pc" object-id="pc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> The majority of pathogenic variants are heterozygous missense variants; in some individuals, small in-frame deletions and nonsense variants have been reported. Most pathogenic variants occur in the highly conserved helix boundary motif domains located at either end of the alpha-helical keratin rod domain.</p>
            <p><bold>Normal gene product.</bold> The protein, keratin, type I cytoskeletal 16 (K16), consists of 473 amino acids. Keratins form a cytoskeletal network within all epithelial cells.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p>
          </sec>
          <sec id="pc.KRT17">
            <title>
              <italic toggle="yes">KRT17</italic>
            </title>
            <p><bold>Gene structure.</bold> The cDNA comprises 1574 bp in eight exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pc" object-id="pc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> The majority of pathogenic variants are heterozygous missense variants; in some individuals, small in-frame deletions have been reported. The majority of pathogenic variants in <italic toggle="yes">KRT17</italic> occur in the helix initiation motif, in which several recurrent pathogenic variants have been observed, particularly c.275A&#x0003e;G (<xref ref-type="table" rid="pc.T.selected_krt17_pathogenic_allelic_v">Table 4</xref>).</p>
            <table-wrap id="pc.T.selected_krt17_pathogenic_allelic_v" position="anchor" orientation="portrait">
              <label>Table 4. </label>
              <caption>
                <p>Selected <italic toggle="yes">KRT17</italic> Pathogenic Allelic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_pc.T.selected_krt17_pathogenic_allelic_v_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_pc.T.selected_krt17_pathogenic_allelic_v_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_pc.T.selected_krt17_pathogenic_allelic_v_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_pc.T.selected_krt17_pathogenic_allelic_v_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.275A&#x0003e;G</td>
                    <td headers="hd_h_pc.T.selected_krt17_pathogenic_allelic_v_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn92Ser</td>
                    <td headers="hd_h_pc.T.selected_krt17_pathogenic_allelic_v_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000422.2">
                        <underline>NM_000422.2</underline>
                      </ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000413.1">
                        <underline>NP_000413.1</underline>
                      </ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The protein, keratin, type I cytoskeletal 17 (K17), consists of 432 amino acids. Keratins form a cytoskeletal network within all epithelial cells.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants cause disruption of the cytoskeleton resulting in keratin filament aggregation leading to collapse of the cytoskeleton and cell fragility. The highly conserved helix boundary domains where the majority of pathogenic variants occur are critical during normal keratin filament assembly.</p>
          </sec>
        </sec>
      </sec>
      <sec id="pc.References">
        <title>References</title>
        <sec id="pc.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="pc.Literature_Cited.reflist0">
            <ref id="pc.REF.eliason.2012.680">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eliason</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>CD</given-names>
                  </name>
                </person-group>
                <article-title>A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2012</year>
                <volume>67</volume>
                <fpage>680</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22264670</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.feng.2003.452">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>YG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>SX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>XR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>WQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Keratin 17 mutation in pachyonychia congenita type 2 with early onset sebaceous cysts.</article-title>
                <source>Br J Dermatol.</source>
                <year>2003</year>
                <volume>148</volume>
                <fpage>452</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12653736</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.fu.2011.1025">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>JY</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2011</year>
                <volume>131</volume>
                <fpage>1025</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21160496</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.goldberg.2014.279">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fruchter</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meilick</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sprecher</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Best treatment practices for pachyonychia congenita.</article-title>
                <source>JEADV</source>
                <year>2014</year>
                <volume>28</volume>
                <fpage>279</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">23363249</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.gruber.2012.e193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edlinger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaspar</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milstone</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidoroff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fritsch</surname>
                    <given-names>PO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmuth</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>An appraisal of oral retinoids in the treatment of pachyonychia congenita.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2012</year>
                <volume>66</volume>
                <fpage>e193</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21601946</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.hickerson.2009.82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hickerson</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leake</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pho</surname>
                    <given-names>LN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaspar</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <article-title>Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients.</article-title>
                <source>J Dermatol Sci.</source>
                <year>2009</year>
                <volume>56</volume>
                <fpage>82</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19699613</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.hickerson.2008.594">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hickerson</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeves</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Contag</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leake</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milstone</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaspar</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <article-title>Single-nucleotide-specific siRNA targeting in a dominant-negative skin model.</article-title>
                <source>J Invest Dermatol</source>
                <year>2008</year>
                <volume>128</volume>
                <fpage>594</fpage>
                <lpage>605</lpage>
                <pub-id pub-id-type="pmid">17914454</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.leachman.2008.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hickerson</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hull</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milstone</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bale</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roop</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaspar</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <article-title>Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita.</article-title>
                <source>J Dermatol Sci</source>
                <year>2008</year>
                <volume>51</volume>
                <fpage>151</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18495438</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.leachman.2010.442">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hickerson</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bullough</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutcherson</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boucher</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eliason</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srivatsa</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornbrust</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milstone</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaspar</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <article-title>First-in-human mutation-targeted siRNA Phase Ib trial of an inherited skin disorder.</article-title>
                <source>Mol Ther.</source>
                <year>2010</year>
                <volume>18</volume>
                <fpage>442</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19935778</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.leachman.2005.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaspar</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleckman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florell</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunny</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milstone</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steensel</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munro</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Toole</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Celebi</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kansky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>EB</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and pathological features of pachyonychia congenita.</article-title>
                <source>J Investig Dermatol Symp Proc.</source>
                <year>2005</year>
                <volume>10</volume>
                <fpage>3</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">16250204</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.lin.2012.558">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y.</given-names>
                  </name>
                </person-group>
                <article-title>Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2012</year>
                <volume>90</volume>
                <fpage>558</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">22405088</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.liao.2007.199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sayers</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irvine</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baselga</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayliss</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uliana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fimiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                </person-group>
                <article-title>A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita.</article-title>
                <source>J Dermatol Sci</source>
                <year>2007</year>
                <volume>48</volume>
                <fpage>199</fpage>
                <lpage>205</lpage>
                <pub-id pub-id-type="pmid">17719747</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.mclean.2011.1015">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eliason</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                </person-group>
                <article-title>The phenotypic and molecular genetic features of pachyonychia congenita.</article-title>
                <source>J Invest Dermatol</source>
                <year>2011</year>
                <volume>131</volume>
                <fpage>1015</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21430705</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.pho.2011.1077">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pho</surname>
                    <given-names>LN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konecki</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bale</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eliason</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Paternal germ cell mosaicism in autosomal dominant pachyonychia congenita.</article-title>
                <source>Arch Dermatol.</source>
                <year>2011</year>
                <volume>147</volume>
                <fpage>1077</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">21576551</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.pohler.2012.1272">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pohler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamai</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirst</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zamiri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horn</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irvine</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goh</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandilands</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suehiro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konohana</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shboul</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teissier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boussofara</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denguezli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribaa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dopping-Hepenstal</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goudie</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reversade</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munro</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                </person-group>
                <article-title>Happloinsufficiency for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>1272</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23064416</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.schwartz.2013.42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerman</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sprecher</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Pachyonychia Congenita Project: A Partnership of Patient and Medical Professional.</article-title>
                <source>J Derm Nurses Association.</source>
                <year>2013</year>
                <volume>5</volume>
                <fpage>42</fpage>
                <lpage>47</lpage>
              </element-citation>
            </ref>
            <ref id="pc.REF.shah.2014.146">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kenner-Bell</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rademaker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paller</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <article-title>Pachyonychia congenita in pediatric patients: natural history, features, and impact.</article-title>
                <source>JAMA Dermatol.</source>
                <year>2014</year>
                <volume>150</volume>
                <fpage>146</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">24132595</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.smith.2005.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassidy</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamill</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joval</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steensel</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjorck</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callif-Daley</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pals</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munro</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                </person-group>
                <article-title>The genetic basis of pachyonychia congenita.</article-title>
                <source>J Investig Dermatol Symp Proc</source>
                <year>2005</year>
                <volume>10</volume>
                <fpage>21</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16250206</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.spaunhurst.2012.875">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spaunhurst</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogendorf</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lingala</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cywinska-Bernas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeman</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>JY</given-names>
                  </name>
                </person-group>
                <article-title>Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.</article-title>
                <source>Br J Dermatol.</source>
                <year>2012</year>
                <volume>166</volume>
                <fpage>875</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22098151</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.szeverenyi.2008.351">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Szeverenyi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassidy</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Common</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogg</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sim</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goh</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simpson</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chee</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunny</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chuon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkatesh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khoo</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>EB</given-names>
                  </name>
                </person-group>
                <article-title>The human intermediate filament database: comprehensive information on a gene family involved in many human diseases.</article-title>
                <source>Hum Mutat</source>
                <year>2008</year>
                <volume>29</volume>
                <fpage>351</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">18033728</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.swartling.2010.1072">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swartling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlqvist</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hymnelius</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahlquist</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Botulinum toxin in the treatment of sweat-worsened foot problems in patients with epidermolysis bullosa simplex and pachyonychia congenita.</article-title>
                <source>Br J Dermatol.</source>
                <year>2010</year>
                <volume>163</volume>
                <fpage>1072</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20618323</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.swartling.2006.763">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swartling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahlquist</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Treatment of pachyonychia congenita with plantar injections of botulinum toxin.</article-title>
                <source>Br J Dermatol.</source>
                <year>2006</year>
                <volume>154</volume>
                <fpage>763</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16536826</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.wilson.2013.58">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azkur</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kocabas</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coskun</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hull</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                </person-group>
                <article-title>Recessive mutations in the gene encoding frizzled 6 cause twenty nail dystrophy--expanding the differential diagnosis for pachyonychia congenita.</article-title>
                <source>J Dermatol Sci.</source>
                <year>2013</year>
                <volume>70</volume>
                <fpage>58</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">23374899</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.wilson.2011.1018">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMullan</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milstone</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hull</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                </person-group>
                <article-title>A large mutational study in pachyonychia congenita.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2011</year>
                <volume>131</volume>
                <fpage>1018</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">21326300</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.wilson.2010.425">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messenger</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leachman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Toole</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                </person-group>
                <article-title>Keratin K6c mutations cause focal palmoplantar keratoderma.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2010</year>
                <volume>130</volume>
                <fpage>425</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19609311</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.wilson.2014.343">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Toole</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milstone</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shepherd</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Asadi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sprecher</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                </person-group>
                <article-title>The molecular genetic analysis of the expanding pachyonychia congenita case collection.</article-title>
                <source>Br J Dermatol.</source>
                <year>2014</year>
                <volume>171</volume>
                <fpage>343</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">24611874</pub-id>
              </element-citation>
            </ref>
            <ref id="pc.REF.zhao.2011.1045">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gartner</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                </person-group>
                <article-title>Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2011</year>
                <volume>131</volume>
                <fpage>1045</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">21390048</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="pc.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="pc.Suggested_Reading.reflist0">
            <ref id="pc.REF.smith.2008.50">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hickerson</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sayers</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeves</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Contag</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leake</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaspar</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WHI</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Development of therapeutic siRNAs for pachyonychia congenita.</article-title>
                <source>J Invest Dermatol</source>
                <volume>128</volume>
                <fpage>50</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17762855</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="pc.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="pc.Author_Notes">
          <title>Author Notes</title>
          <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.transderminc.com/"><underline>TransDerm, Inc</underline></ext-link> is a therapeutic company dedicated to finding treatment for rare skin disorders.</p>
        </sec>
        <sec id="pc.Acknowledgments">
          <title>Acknowledgments</title>
          <p>We thank the many affected individuals and the clinicians without whose input our work into the genetic basis of PC would not have been possible. Thanks to Holly Evans of PC Project for helping with IPCRR data preparation. Research into the genetic basis and treatment of keratin disorders in the WHIM lab has been supported by The Wellcome Trust, DEBRA UK, and The PC Project.</p>
        </sec>
        <sec id="pc.Author_History">
          <title>Author History</title>
          <p>C David Hansen, MD (2011-present)Peter R Hull, MD, PhD, FRCPC (2011-present)Roger L Kaspar, PhD (2006-present)Sancy A Leachman, MD, PhD; University of Utah (2006-2014)WH Irwin McLean, DSc, FRSE (2006-present)Leonard M Milstone, MD (2011-present)Edel O&#x02019;Toole, MD, PhD, FRCPI, FRCP (2014-present)Mary E Schwartz, LLD (2006-present)Frances JD Smith, PhD (2006-present)Eli Sprecher, MD, PhD (2011-present)Maurice van Steensel, MD, PhD (2014-present)</p>
        </sec>
        <sec id="pc.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>24 July 2014 (me) Comprehensive updated posted live</p>
            </list-item>
            <list-item>
              <p>1 December 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>25 June 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>6 December 2007 (cd) Revision: clarification of PC phenotypes</p>
            </list-item>
            <list-item>
              <p>27 January 2006 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>14 July 2005 (rlk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="pc.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Common findings of pachyonychia congenita include: thickened and dystrophic nails (both fingernails and toenails) (a-c); bullae (usually on the pressure points of the heels and soles); hyperkeratosis (d-e); cysts (f); and oral leukokeratosis (g).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pc-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="pc.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Schematic diagram showing the basic protein structure of a keratin filament. The &#x003b1;-helical rod domain is divided into four domains: 1A, 1B, 2A, and 2B, connected by non-helical linkers L1, L12, and L2. At the ends of the rod domain are the helix initiation motif (shaded red) and helix termination motif (shaded red) that are highly conserved in sequence between keratins. The majority of pathogenic variants found in PC in <italic toggle="yes">KRT6A</italic>, <italic toggle="yes">KRT6B</italic>, <italic toggle="yes">KRT6C</italic>, <italic toggle="yes">KRT16</italic>, and <italic toggle="yes">KRT17</italic> fall within these highly conserved domains.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pc-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
